China and India are the leading exporters of Edaravone, accounting for the majority of global shipments, while the United States, Germany, and Japan represent the largest importers—driven by pharmaceutical manufacturing and clinical demand. Edaravone prices have remained relatively stable amid consistent export volumes from Asian suppliers. Exports from China have grown modestly year-on-year since 2022, while Indian exports have plateaued, and U.S. imports have increased steadily, reflecting ongoing regulatory approvals and expanded neuroprotective therapy adoption.
Edaravone is a white to off-white crystalline solid at room temperature, with a melting point of approximately 128–132 °C and low volatility. It is an aromatic heterocyclic compound, specifically a pyrazolone derivative, featuring a fused five-membered ring system with nitrogen and carbonyl functionalities. Primarily manufactured as an active pharmaceutical ingredient (API), edaravone is not used as a chemical intermediate in bulk industrial synthesis but is produced for direct incorporation into finished dosage forms. Its sole commercial application is in human therapeutics, where it serves as a neuroprotective agent indicated for the treatment of amyotrophic lateral sclerosis (ALS) and acute ischemic stroke in select markets.
antioxidant, lipoxygenase inhibitor
Off white to light yellow powder
This chemical is included in Fine Chemicals. See more about what is Edaravone and Edaravone SDS information.
Find Edaravone supply and Edaravone suppliers on Guidechem to meet your sourcing needs from 761 trusted and certifedsuppliers.
Guidechem assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness, fitness for purpose or timeliness.